These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12013964)

  • 1. [Parathyroid dysfunction and mitochondrial diseases].
    Ohno Y; Aoki N
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():647-51. PubMed ID: 12013964
    [No Abstract]   [Full Text] [Related]  

  • 2. [Single deletion of mitochondrial DNA: CPEO, Kearns-Sayre syndrome].
    Arisato T; Higuchi I; Nakagawa M
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():458-61. PubMed ID: 12013912
    [No Abstract]   [Full Text] [Related]  

  • 3. [Heart block].
    Nakano K; Nakayama T; Sasaki K
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():652-5. PubMed ID: 12013965
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chronic progressive external ophthalmoplegia (CPEO), Kearns-Sayre syndrome (KSS)].
    Ishikawa H; Nishino I
    Ryoikibetsu Shokogun Shirizu; 2001; (36):153-6. PubMed ID: 11596351
    [No Abstract]   [Full Text] [Related]  

  • 5. [Autosomal recessive chronic progressive external ophthalmoplegia].
    Inose M; Higuchi I
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():455-7. PubMed ID: 12013911
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ophthalmoplegia].
    Terada M; Mitsunami K; Maeda K; Yasuda H
    Nihon Rinsho; 2002 Apr; 60 Suppl 4():522-5. PubMed ID: 12013931
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mitochondrial DNA mutations in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome].
    Wang ZX; Yuan Y; Gao F; Qi Y; Shen DG; Chen QT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Aug; 20(4):273-8. PubMed ID: 12903032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic progressive external ophthalmoplegia--symptom or syndrome?].
    Bau V; Deschauer M; Zierz S
    Klin Monbl Augenheilkd; 2009 Oct; 226(10):822-8. PubMed ID: 19830638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progressive external ophthalmoplegia and the Kearns-Sayre syndrome: a clinical and molecular study of 6 cases].
    Barrientos A; Casademont J; Grau JM; Cardellach F; Montoya J; Estivill X; Urbano-Márquez A; Nunes V
    Med Clin (Barc); 1995 Jul; 105(5):180-4. PubMed ID: 7630231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of Kearns-Sayre syndrome with autoimmune thyroiditis and possible Hashimoto encephalopathy.
    Berio A; Piazzi A
    Panminerva Med; 2002 Sep; 44(3):265-9. PubMed ID: 12094144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion screening of mitochondrial DNA via multiprimer DNA amplification.
    Ernst BP; Wilichowski E; Wagner M; Hanefeld F
    Mol Cell Probes; 1994 Feb; 8(1):45-9. PubMed ID: 8028607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel 7301-bp deletion in mitochondrial DNA in a patient with Kearns-Sayre syndrome, diabetes mellitus, and primary amenorrhoea.
    De Block CE; De Leeuw IH; Maassen JA; Ballaux D; Martin JJ
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):80-3. PubMed ID: 15031771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes.
    Zupanc ML; Moraes CT; Shanske S; Langman CB; Ciafaloni E; DiMauro S
    Ann Neurol; 1991 Jun; 29(6):680-3. PubMed ID: 1892371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial genome analysis in Kearns-Sayre syndrome.
    Lertrit P; Atchaneeyasakul L; Devahastin V; Saechan V; Sangruchi T; Neungton N; Lekhakula S
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():162-5. PubMed ID: 8629098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ocular mitochondrial myopathies: a spectrum of clinical presentations].
    Glutz von Blotzheim S; Borruat FX; Hirt L
    Klin Monbl Augenheilkd; 1998 May; 212(5):299-300. PubMed ID: 9677561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: can we predict progression?
    Auré K; Ogier de Baulny H; Laforêt P; Jardel C; Eymard B; Lombès A
    Brain; 2007 Jun; 130(Pt 6):1516-24. PubMed ID: 17439982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuro-ophthalmologic manifestations of mitochondrial DNA disorders: chronic progressive external ophthalmoplegia, Kearns-Sayre syndrome, and Leber's hereditary optic neuropathy.
    Kosmorsky G; Johns DR
    Neurol Clin; 1991 Feb; 9(1):147-61. PubMed ID: 2011107
    [No Abstract]   [Full Text] [Related]  

  • 18. CPEO and KSS differ in the percentage and location of the mtDNA deletion.
    López-Gallardo E; López-Pérez MJ; Montoya J; Ruiz-Pesini E
    Mitochondrion; 2009 Sep; 9(5):314-7. PubMed ID: 19410662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MELAS + KSS].
    Goto Y
    Ryoikibetsu Shokogun Shirizu; 2001; (36):157-8. PubMed ID: 11596352
    [No Abstract]   [Full Text] [Related]  

  • 20. A PCR test for progressive external ophthalmoplegia and Kearns-Sayre syndrome on DNA from blood samples.
    De Coo IF; Gussinklo T; Arts PJ; Van Oost BA; Smeets HJ
    J Neurol Sci; 1997 Jul; 149(1):37-40. PubMed ID: 9168163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.